Ironwood Pharmaceuticals Cash Flow Statement
NASDAQ: IRWDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ironwood Pharmaceuticals free cash flow
In fiscal 2025, Ironwood Pharmaceuticals generated $127.0 million of operating cash flow and spent $34,000 on capital expenditures. That left free cash flow of $127.0 million, a free-cash-flow margin of 42.9% of revenue. Free cash flow was up 22.8% from the prior year's $103.4 million.
Summary generated from market data by MetaCap's automated system. Methodology
Ironwood Pharmaceuticals cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 24.02M | 880.00K | -1.03B | 175.06M | 528.45M | 106.18M | 21.50M | -282.37M | -116.94M | -81.71M |
| Net Income growth (YoY) | +2629.20% | — | -689.24% | -66.87% | +397.71% | +393.73% | — | — | — | — |
| Depreciation & Amortization | 1.10M | 1.20M | 1.20M | 1.40M | 1.50M | 2.30M | 5.60M | 3.90M | 6.40M | 10.28M |
| Stock-Based Compensation | 17.25M | 29.85M | 32.01M | 27.05M | 22.28M | 31.18M | 31.28M | 40.53M | 30.91M | 29.22M |
| Change in Working Capital | 41.80M | 26.17M | 12.98M | 30.00K | 5.01M | -3.81M | -100.56M | 3.78M | -24.49M | 2.00M |
| Operating Cash Flow | 127.04M | 103.55M | 183.43M | 273.76M | 261.89M | 168.84M | 10.72M | -70.88M | -100.75M | -25.93M |
| Capital Expenditures | -34.00K | -142.00K | -273.00K | -136.00K | -265.00K | -1.84M | -7.19M | -351.00K | -2.80M | -4.21M |
| Investing Cash Flow | -34.00K | -142.00K | -1.03B | -136.00K | -265.00K | -1.84M | -11.14M | 88.87M | 151.46M | -177.67M |
| Share Repurchases | — | — | — | -126.39M | -24.13M | — | — | — | — | — |
| Debt Issued | — | — | — | — | — | — | — | — | 146.25M | — |
| Debt Repaid | — | — | — | — | — | — | — | — | -134.26M | -26.87M |
| Financing Cash Flow | 216.00K | -106.97M | 277.16M | -237.55M | -4.55M | 18.55M | -1.19M | 30.07M | 19.84M | -4.18M |
| Net Change in Cash | 126.90M | -3.60M | -565.78M | 36.07M | 257.08M | 185.54M | -1.60M | 48.06M | 70.54M | -207.78M |
| Free Cash Flow | 127.01M | 103.41M | 183.15M | 273.63M | 261.63M | 166.99M | 3.54M | -71.23M | -103.56M | -30.14M |
This table shows 10 annual periods of Ironwood Pharmaceuticals's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow IRWD's reporting calendar. What is a cash flow statement?